n psychiatry, clinical judgment has been the predominant method of diagnosis. The `gold standard? for clinical research is the Structured Clinical Interview for DSM-5 (SCID-5). The SCID-5 promotes reliability, but its validity is questionable. There is growing recognition that biomarkers can be used to identify more homogeneous patient populations, but there is substantial phenotypic discordance for schizophrenia even in identical twins. In the absence of symptom data, biomarkers alone are unlikely to yield a clinical diagnosis. In a past SBIR project, TeleSage Inc. successfully converted the paper SCID into a web-based software program. The NetSCID-5 is now widely used in research. Nevertheless, in order to achieve the goal of ?turning clinical care networks into centers for research? (Insel, Director's Blog, 2012) and furthering the RDoC initiative, we need a means of gathering rigorous diagnostic data in routine clinical care. This software must (a) require minimal clinician time, (b) allow clinics to bill according to the current DSM-5 categories, and (c) be able to gather the large amount of data necessary to inform a broad research agenda including machine learning techniques. TeleSage proposes to develop a self-report diagnostic assessment that satisfies both immediate clinical needs and broader research goals: the ?Screening Interview for Diagnosis? or SID. TeleSage has worked with an expert panel including Dr. Michael First, the primary author of the SCID- 5, iteratively developing and testing self-report items. Based on expert panel review and cognitive interviewing, we identified a final set of 661 unique self-report, Likert-scale items covering all of the individual sub-symptoms described within each of the SCID criteria. TeleSage has also created a behavioral health PORTAL that includes the NetSCID-5, IRT/CAT item administration, randomization, and longitudinal reporting capabilities. The PORTAL exchanges data and reports with several EHRs including the NetSmart EHR system. This Direct-to-Phase II application aims to create the SID, which will (a) reside on our existing secure web PORTAL, (b) administer simple Likert-scale self-report items, (c) generate DSM-5 and ICD-10 diagnoses for billing, (d) use minimal clinician time, (e) pull pre-defined data fields from the EHR (e.g. family history, demographic, and biomarker data), (f) be able to add new self-report items for exploration, (g) integrate with machine learning tools, and (h) send raw data and interpretive reports to EHR systems. Because of these features, we believe that the SID has the potential to be used widely by both clinicians and researchers. The SID is intended to help transcend DSM-5 and to support RDoC. The SID product must be commercially successful and useful both in routine clinical care and research. The SID is intended to facilitate the development and evolution of a new behavioral health nosology based on the aggregation of biomarker and symptom data, a nosology that is more analogous to those found in other fields of medicine.

Public Health Relevance

The Structured Clinical Interview for DSM-5 (SCID-5) represents the current diagnostic gold standard in behavioral health and yields much more reliable diagnoses than the unstructured patient interviews that predominate in clinical settings; however, the full SCID-5 is a lengthy and complex paper-and-pencil instrument that takes approximately 90 minutes to administer and is thus seldom used outside of clinical research settings. We want to create a new, self-report software tool that will save clinicians time relative to the paper SCID, significantly reduce diagnostic error rates, greatly increase the reliability of diagnoses in routine clinical care, and integrate seamlessly into Electronic Health Record (EHR) systems: the Screening Inventory for Diagnosis (SID). The SID is a self-report, computer-adaptive diagnostic assessment, based on easy-to- understand, five-point Likert-scale items. The SID is intended to help transcend DSM-5, support RDoC, and facilitate the development and evolution of a new behavioral health nosology based on the aggregation of biomarker and symptom data.

National Institute of Health (NIH)
National Institute of Mental Health (NIMH)
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Grabb, Margaret C
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Telesage, Inc.
Chapel Hill
United States
Zip Code